NCT05020444View on ClinicalTrials.gov

TriPRIL CAR T Cells in Multiple Myeloma

PHASE1RecruitingINTERVENTIONAL

Enrollment

18

Participants

Timeline

Start Date

October 5, 2021

Primary Completion Date

January 1, 2026

Study Completion Date

January 1, 2028

Conditions

Multiple MyelomaMultiple Myeloma in RelapseRefractory Multiple Myeloma

Interventions

DRUG

TriPRIL CAR T Cells

Intravenous infusion

DRUG

Cyclophosphamide

Intravenous infusion

DRUG

Fludarabine

Intravenous infusion

Trial Locations (1)

02114

RECRUITING

Massachusetts General Hospital Cancer Center, Boston

All Listed Sponsors

lead

Marcela V. Maus, M.D.,Ph.D.

OTHER